Modulation of glutamate receptors in response to the novel antipsychotic olanzapine in rats

Biological Psychiatry

Volumn 50, Issue 2, 2001, Pages 117-122

  Tascedda, Fabio ^a   Blom, Joan M C ^a,b   Brunello, Nicoletta ^a   Zolin, Katia ^b,c   Gennarelli, Massimo ^c   Colzi, Anna ^d   Bravi, Daniele ^d   Carra, Serena ^a   Racagni, Giorgio ^b,c   Riva, Marco A ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^d Eli Lilly Italia SpA   (Italy)

Author keywords

Adaptation; Clozapine; Gene expression; Haloperidol; Hippocampus; Schizophrenia

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CLOZAPINE; GLUTAMATE RECEPTOR; HALOPERIDOL; IONOTROPIC RECEPTOR; MESSENGER RNA; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; OLANZAPINE; RECEPTOR SUBTYPE; SODIUM CHLORIDE;

ADAPTATION; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOSE TIME EFFECT RELATION; DRUG EXPOSURE; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; FRONTAL CORTEX; LONG TERM EXPOSURE; MALE; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; REGULATORY MECHANISM; RNA ANALYSIS; SCHIZOPHRENIA;

ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; FRONTAL LOBE; HIPPOCAMPUS; MALE; PIRENZEPINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RECEPTORS, GLUTAMATE; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER;

EID: 0035878542     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(01)01135-0     Document Type: Article

References (36)

1. Phencyclidine-induced psychosis
2. Structural abnormalities in the frontal system in schizophrenia. A magnetic resonance imaging study
3. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidences
4. Expression of messenger RNAs encoding ionotropic glutamate receptors in rat brain: Regulation by haloperidol
5. Olanzapine: A basic science update
6. Interactions between glutamatergic and monoaminergic systems within the basal ganglia - Implications for schizophrenia and Parkinson's disease
7. A glutamatergic deficiency model of schizophrenia
8. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
9. Cognitive impairment associated with morphological brain abnormalities on computed tomography in chronic schizophrenic patients
10. An integrated view of pathophysiological models of schizophrenia
11. The effect of chronic haloperidol treatment on glutamate receptor subunit (GluR1, GluR2, KA1, KA2, NR1) mRNAs and glutamate binding protein mRNA in rat forebrain
12. GluR2 glutamate receptor subunit flip and flop isoforms are decreased in the hippocampal formation in schizophrenia: A reverse transcriptase-polymerase chain reaction (RT-PCR) study
13. Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs
14. Dopamine-glutamate interactions in the striatum: Behaviourally relevant modification of excitotoxicity by dopamine receptor-mediated mechanisms
15. Clozapine and haloperidol differentially affect AMPA and kainate receptor subunit mRNA levels in rat cortex and striatum
16. The role of N-methyl-D-aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes
17. Glutamatergic control of dopamine release during stress in the rat prefrontal cortex
18. The neuropsychopharmacology of phencyclidine: From NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia
19. Hippocampal pathologic findings in schizophrenia. A morphometric study
20. The prefrontal cortex regulates the basal release of dopamine in the limbic striatum: An effect mediated by ventral tegmental area
21. Development, disease and degeneration in schizophrenia: A unitary pathophysiological model
22. Mechanisms of action of atypical antipsychotic drugs: A critical analysis
23. Glutamate receptor expression in schizophrenic brain
24. Pre-clinical pharmacology of atypical antipsychotic drugs: A selective review
25. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats
26. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia
27. NMDA receptor hypofunction model of schizophrenia
28. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol
29. Regulation of NMDA receptor subunit messenger RNA levels in the rat brain following acute and chronic exposure to antipsychotic drugs
30. The TINS/TiPS Lecture. The molecular biology of mammalian glutamate receptor channels
31. Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of "neuroleptic-free" schizophrenics: Evidence on reversible up-regulation by typical neuroleptics
32. Glutamatergic aspects of schizophrenia
33. Regulation of ionotropic glutamate receptors in the rat brain in response to the atypical antipsychotic seroquel (quetiapine fumarate)
34. Schizophrenia and the frontal lobe
35. Cell biology of the hippocampal formation in schizophrenia
36. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: A search for common ground